Faculty Opinions recommendation of Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma.
Keyword(s):
2013 ◽
Vol 188
(11)
◽
pp. 1294-1302
◽
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 85
(2)
◽
pp. 304-315
◽
Keyword(s):
2010 ◽
Vol 31
(6)
◽
pp. 461-471
◽